Equity Profile

SNN

Smith & Nephew plc

Health CareHealth Care Equipment$13.0B

Feb20Thu

Pre-Earnings Brief

UpcomingQ4-2019Pre-Market9:00 AM EST

Company Snapshot

Smith & Nephew plc (SNN) is a global medical technology company that specializes in advanced wound management, surgical devices, and orthopedic reconstruction. Operating in the health care sector, it plays a crucial role in improving patient outcomes and enhancing the quality of care through innovative medical equipment.

Key Metrics to Watch

Revenue Growth

Revenue growth is essential to gauge the company's ability to expand its market share and meet demand in the health care equipment sector.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and financial health, which investors closely monitor.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q4-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported an EPS of $0.92, reflecting stable performance. The stock saw a modest increase of 1.23% the following day, indicating a positive market reception.

Management Promises & Guidance

Focus on innovation in wound management products.
Commitment to expanding into emerging markets.
Continued investment in research and development.

Expectations

Wall Street Expectations

Overall, expectations for Smith & Nephew's upcoming earnings are mixed, with no analyst estimates available. Investors are keen to see how the company navigates challenges in the health care sector.

Bull Case

The optimistic view hinges on strong revenue growth driven by new product launches and successful market penetration, potentially leading to improved EPS.

Bear Case

Conversely, the pessimistic outlook considers potential supply chain issues and competitive pressures that could hinder revenue growth and profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for the upcoming quarter?

Revenue growth will be a key indicator of the company's ability to capture market demand and sustain its competitive edge.

How is Smith & Nephew addressing supply chain challenges?

Supply chain issues could significantly impact production and sales, making this a critical point for investors to understand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the impact of Smith & Nephew's recent product innovations, which could drive unexpected revenue growth this quarter.

Supporting Evidence

The company's focus on emerging markets may yield higher-than-expected sales.

Recent trends in health care spending suggest increased demand for innovative medical solutions.

Options pricing indicates a higher volatility expectation than historical averages, suggesting potential for significant movement.

Key Risk

If revenue growth exceeds 10%, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be pivotal in assessing the company's growth trajectory and operational efficiency amidst industry challenges.

Bull Confirmed If

Achieving revenue growth of over 10% year-over-year would confirm the bull case.

Bear Confirmed If

A decline in revenue or EPS below previous quarters would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a 5% potential move in either direction, indicating uncertainty around the earnings report.

Options are pricing ±5.0% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

25.2%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could rise by around 2.89%, confirming a positive outlook.

In-Line / Cautious

An in-line report with cautious management commentary may lead to a muted reaction as investors weigh future growth prospects.

Miss

A miss could result in a decline of approximately 1.11%, reflecting investor disappointment and concerns over operational challenges.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on new product launches and their expected impact on revenue.
2Updates on supply chain management strategies.
3Insights into market expansion efforts in emerging regions.
4Any changes in guidance for the upcoming quarters.
5Management's perspective on competitive pressures in the health care equipment sector.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Feb17

SCIReported

Service Corporation International

RecapView

Feb17

FLSReported

Company Snapshot

Key Metrics to Watch

Revenue Growth

Revenue growth is essential to gauge the company's ability to expand its market share and meet demand in the health care equipment sector.

N/A

Earnings Per Share (EPS)

EPS is a key indicator of profitability and financial health, which investors closely monitor.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

SNN Q4-2019 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

+19.92%

Avg Stock Reaction

+0.05%

Last Quarter Recap

In the last quarter, Smith & Nephew reported an EPS of $0.92, reflecting stable performance. The stock saw a modest increase of 1.23% the following day, indicating a positive market reception.

Management Promises & Guidance

Focus on innovation in wound management products.
Commitment to expanding into emerging markets.
Continued investment in research and development.

Expectations

Wall Street Expectations

Overall, expectations for Smith & Nephew's upcoming earnings are mixed, with no analyst estimates available. Investors are keen to see how the company navigates challenges in the health care sector.

Bull Case

The optimistic view hinges on strong revenue growth driven by new product launches and successful market penetration, potentially leading to improved EPS.

Bear Case

Conversely, the pessimistic outlook considers potential supply chain issues and competitive pressures that could hinder revenue growth and profitability.

Expectations

Two Questions That Matter

The print will turn on these two things.

What is the expected revenue growth for the upcoming quarter?

Revenue growth will be a key indicator of the company's ability to capture market demand and sustain its competitive edge.

How is Smith & Nephew addressing supply chain challenges?

Supply chain issues could significantly impact production and sales, making this a critical point for investors to understand.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate the impact of Smith & Nephew's recent product innovations, which could drive unexpected revenue growth this quarter.

Supporting Evidence

The company's focus on emerging markets may yield higher-than-expected sales.

Recent trends in health care spending suggest increased demand for innovative medical solutions.

Options pricing indicates a higher volatility expectation than historical averages, suggesting potential for significant movement.

Key Risk

If revenue growth exceeds 10%, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be pivotal in assessing the company's growth trajectory and operational efficiency amidst industry challenges.

Bull Confirmed If

Achieving revenue growth of over 10% year-over-year would confirm the bull case.

Bear Confirmed If

A decline in revenue or EPS below previous quarters would validate the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±5%

Historical Avg

±2.4%

Pricing rich

The options market is pricing in a 5% potential move in either direction, indicating uncertainty around the earnings report.

Options are pricing ±5.0% while SNN has averaged ±2.4% over the last 8 prints — setup is pricing rich.

Detail

30d HV

25.2%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Smith & Nephew beats expectations, history suggests the stock could rise by around 2.89%, confirming a positive outlook.

In-Line / Cautious

An in-line report with cautious management commentary may lead to a muted reaction as investors weigh future growth prospects.

Miss

A miss could result in a decline of approximately 1.11%, reflecting investor disappointment and concerns over operational challenges.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Details on new product launches and their expected impact on revenue.
2Updates on supply chain management strategies.
3Insights into market expansion efforts in emerging regions.
4Any changes in guidance for the upcoming quarters.
5Management's perspective on competitive pressures in the health care equipment sector.